Brain natriuretic peptide and its relationship to left ventricular hypertrophy in patients on peritoneal dialysis or hemodialysis less than 3 years

Renal Failure

Volumn 28, Issue 2, 2006, Pages 133-139

  Taskapan, M Cagatay ^a   Ulutas, Ozkan ^a   Aksoy, Yuksel ^a   Senel, Soner ^a   Sahin, Ibrahim ^a   Kosar, Feridun ^a   Taskapan, Hulya ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Brain natriuretic peptide (BNP); Hemodialysis (HD); Left ventricular hypertrophy (LVH); Peritoneal dialysis (PD)

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HUMAN; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; URINE VOLUME;

FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PERITONEAL DIALYSIS; RENAL DIALYSIS; TIME FACTORS;

EID: 33645546473     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220500530668     Document Type: Article

References (30)

1. Espiner EA, Richards AM, Yandle TG, Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am. 1995;24:481-509.
2. De Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet. 2003;362:316-322.
3. Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation. 1995;92:1558-1564.
4. Kazanagra R, Cheng V, Garcia A, et al. A rapid test for B-natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386-391.
5. Magga J, Vuolteenaho O, Tokola H, Marttila M, Ruskoaho H. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Ann Med. 1998;30(suppl):39-45.
6. Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension. 1996;28:22-30.
7. Stanton E, Hansen M, Wijeysundera HC, Kupchak P, Hall C, Rouleau JL. PRAISE-2 study investigators. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischemic origin. Eur J Heart Fail. 2005;7(4):557-565.
8. Hulsmann M, Berger R, Mortl D, Gore O, Meyer B, Pacher R. Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: a direct comparison of N-terminal atrial natriuretic peptide, N-terminal brain natriuretic peptide and brain natriuretic peptide. Eur J Heart Fail. 2005;7(4):552-556.
9. Ishizaka Y, Yamamoto Y, Fukunaga T, et al. Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis. 1994;24:461-472.
10. Nitta K, Kawashima A, Yumura W, et al. Plasma concentration of brain natriuretic peptide as an indicator of cardiac ventricular function in patients on hemodialysis. Am J Nephrol. 1998;8:411-415.
11. Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001;59:1559-1566.
12. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic cardiovascular disease in end-stage renal disease: prevalence, associations and prognosis. Kidney Int. 1995;47:186-192.
13. Levey S. Controlling the epidemic of cardiovascular disease in chronic renal disease: where do we start? Am J Kidney Dis. 1998;32(5 suppl 3):S5-S13.
14. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11:1277-1285.
15. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5 suppl 3):S112-S119.
16. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. Am Soc Nephrol. 2001;12:1508-1515.
17. Nakatani T, Naganuma T, Masuda C, Uchida J, Sugimura T, Sugimura K. Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med. 2002;10(4):457-461.
18. Hoeben H, Van Biesen W, Lameire N. Cardiovascular problems in peritoneal dialysis patients: a short review. Perit Dial Int. 1998;19:150-158.
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
20. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation. 1977;55:613-618.
21. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnosis breakthrough for clinicians. Rev Cardiovasc Med. 2003;4:72-80.
22. Chen HH, Burnett JC Jr. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians. 1999;111:406-416.
23. Tonolo G, McMillan M, Polonia J, et al. Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure. Am J Physiol. 1988;254:895-899.
24. Smith MW, Espiner EA, Yandle TG, Charles CJ, Richards AM. Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol. 2000;167:239-246.
25. Kohse KP, Feifel K, Mayer-Wehrstein R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol. 1993;40:83-90.
26. Iwashima Y, Horio T, Takami Y, et al. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis. 2002;40:974-982.
27. Fagugli RM, Palumbo B, Ricciardi D, et al. Association between brain natriuretic peptide and extracellular water in hemodialysis patients. Nephron Clin Pract. 2003;95(2):c60-c66.
28. Goto T, Takase H, Toriyama T, et al. Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron. 2002;92:610-615.
29. Ishii J, Ishikawa T, Yukitake J, et al. Clinical specificity of a second-generation cardiac troponin T assay in patients with chronic renal failure. Clin Chim Acta. 1998;270:183-188.
30. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and predict mortality in dialysis patients. Am Soc Nephrol. 2001;12:1508-1515.